Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.00
Ask:
2.20
Spread: 0.20 (10.00%)
Market Cap: £44.34m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Valkor update

26 Sep 2025 07:00

RNS Number : 9845A
Quadrise PLC
26 September 2025
 

Certain of the information contained within this announcement is deemed by the Company to constitute inside information as stipulated under The Market Abuse Regulation (EU 596/2014) pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

 

26 September 2025

 

Quadrise plc

("Quadrise", "QED" or the "Company")

 

Valkor update

 

Quadrise plc (AIM: QED), the technology company focused on the decarbonisation of shipping and heavy industry through deployment of low emission fuels and biofuels, confirms the signature of an addendum (the "Addendum") to the June 2023 Site License and Supply Agreement ("SLS Agreement") with Valkor Technologies LLC ("Valkor") in Utah, USA.

 

Pursuant to the Addendum, the payment of US$1.0 million due to the Company under the SLS Agreement (as amended) has been re-phased over the period to 30 June 2026, with the deliveries of Multifuel Manufacturing Units ("MMUs") and associated payments to the Company amended to match updated expectations of oil production ramp-up at the Valkor project site.

 

On 14 January 2025, an addendum to the SLS Agreement was executed by the Parties under which Valkor agreed to pay Quadrise an aggregate of US$1.5 million in exchange for the provision by Quadrise of an MSAR license and the delivery of a smaller Multifuel Manufacturing Unit ("MMU") in 2025 prior to the delivery of a full size MMU thereafter.

Due to slower than expected ramp-up in oil production and resulting financial constraints during the period, Quadrise and Valkor have now agreed a further addendum to the SLS Agreement as follows:

· A re-phased payment of the initial US$1.0m license fee, with a non-refundable amount of US$50k payable immediately, US$0.3 million payable by Valkor on or before 31 March 2026 and the remaining US$0.65 million due on 30 June 2026.

 

· The supply by Quadrise of a smaller Multifuel Manufacturing Unit ("MMU") of 600 bpd capacity on an interim basis by 30 June 2026, for which Valkor will pay US$0.2 million by 30 September 2026. A further US$0.3 million will be due to Quadrise upon supply of a full size 6,000 bpd MMU to Valkor, in exchange for the 600 bpd MMU.

 

· A project development and support services fee of US$75,000 payable quarterly by Valkor from 1 July 2026 for a minimum period of two years, in respect of Quadrise engineering and process design and commissioning services, site operations and compliance support.

 

Commenting on the update, Jason Miles, Chief Technology Officer of Quadrise, said:

 

"We are pleased to have signed this addendum with Valkor, which reflects their continued commitment to deploying Quadrise technology in Utah as a route to market for their heavy sweet oil, whilst also re-organising licence and MMU delivery payments to be received by the Company."

 

"When combined, our respective technologies will provide very attractive low sulphur fuels and biofuels with compelling economics and environmental credentials."

 

Steven Byle, Chief Executive Officer of Valkor, added:

 

"While progress during 2025 has been slower than anticipated, we remain committed to our partnership with Quadrise and to deployment of their technology in Utah.

 

The recent approvals and financing secured for our first mined oil sands marked a significant milestone and we are now focused on increasing oil production and enhancing product quality.

 

Quadrise technology remains a key part of our strategy to unlock higher value markets for our heavy sweet oils and we look forward to working closely with the team to bring these solutions to market."

 

For further information please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Technology Officer

 

 

Nominated Adviser

Cavendish Capital Markets Limited

 

 

+44 (0)20 7220 0500

Ben Jeynes

Katy Birkin

George Lawson

 

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Harry Davies-Ball (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

 

 

+44 (0)20 3005 5000

 

Public & Investor Relations

 

 

Tavistock Communications (Financial PR & IR)

Simon Hudson

Nick Elwes

Ruairi Millar

 

+44 (0) 20 7920 3150

 

 BLUE Communications Limited (Marine & Trade PR)

 Rhys Thomas

 Sam Deacon

 

 

 

+44 (0)7595 227750

+44 (0)7527 558846

 

 

 

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to lower energy costs, pollution and greenhouse gas emissions today for the global power generation, shipping, industrial and oil industries.

Learn more at: www.quadrise.com

 

Follow us on social media:

LinkedIn: @Quadrise Plc

X: @QuadrisePlc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEQLBLEKLLBBX
Date   Source Headline
24th May 20127:00 amRNSFinal Results - Part 2
24th May 20127:00 amRNSFinal Results - Part 1
23rd May 20127:00 amRNSiQ Fund agrees further £70m financing with M&G
15th May 20123:23 pmRNSDirector/PDMR Shareholding
14th May 201210:52 amRNSNotice of Preliminary Results
4th May 20124:02 pmRNSDirector/PDMR Shareholding
30th Apr 201210:35 amRNSBlocklisting Interim Review
3rd Apr 20127:00 amRNSiQ Fund Agrees £158 million refinancing
2nd Apr 201210:32 amRNSTotal Voting Rights
29th Mar 20127:00 amRNSSale of Emersons Green
23rd Mar 201210:58 amRNSDirector/PDMR Shareholding
29th Feb 20124:54 pmRNSTotal Voting Rights
28th Feb 20127:00 amRNSAcquisition
20th Feb 20121:32 pmRNSHolding(s) in Company
16th Feb 20122:44 pmRNSDirectorate Change
2nd Feb 20127:00 amRNSInterim Management Statement
1st Feb 20122:30 pmRNSNotice of IMS
31st Jan 20125:44 pmRNSTotal Voting Rights
17th Jan 201211:04 amRNSDirector/PDMR Shareholding
29th Dec 201110:22 amRNSTotal Voting Rights
13th Dec 20113:33 pmRNSDirector/PDMR Shareholding
29th Nov 20117:00 amRNSHalf Yearly Report
22nd Nov 20112:55 pmRNSHolding(s) in Company
17th Nov 20117:00 amRNSDisposal
14th Nov 20112:20 pmRNSDirector/PDMR Shareholding
4th Nov 20114:04 pmRNSHolding(s) in Company
1st Nov 201110:27 amRNSBlocklisting Interim Review
20th Oct 20112:43 pmRNSNotice of Results
18th Oct 201110:03 amRNSAdditional Listing
13th Oct 20112:34 pmRNSDirector/PDMR Shareholding
13th Oct 20117:00 amRNSDisposal
11th Oct 201110:03 amRNSHolding(s) in Company
10th Oct 20111:10 pmRNSHolding(s) in Company
22nd Sep 20112:30 pmRNSDirector/PDMR Shareholding
21st Sep 20118:30 amRNSHolding(s) in Company
19th Sep 20111:53 pmRNSHolding(s) in Company
16th Sep 20114:57 pmRNSDirector/PDMR Shareholding
6th Sep 20114:31 pmRNSAnnual Information Update
5th Sep 20114:01 pmRNSResult of AGM
31st Aug 20115:20 pmRNSHolding(s) in Company
16th Aug 20111:09 pmRNSDirector/PDMR Shareholding
11th Aug 201110:26 amRNSNotice of AGM
10th Aug 20117:00 amRNSInterim Management Statement
1st Aug 20113:14 pmRNSNotice of IMS
14th Jul 201112:08 pmRNSAnnual Financial Report
13th Jul 20113:10 pmRNSDirector/PDMR Shareholding
6th Jul 20117:00 amRNSDirectorate Change
14th Jun 201111:18 amRNSDirector/PDMR Shareholding
10th Jun 20117:00 amRNSDisposal
9th Jun 20114:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.